000			03146cam a2200385 i 4500
001			on1029779381
003			OCoLC
005			20221230155440.0
008			180316t20182018nyu b 001 0 eng
010			_a 2018000263
020			_a9781524731656 _qhardcover
020			_a152473165X _qhardcover
035			_a(OCoLC)on1029779381
037			_bRandom House Inc, Attn Order Entry 400 Hahn rd, Westminster, MD, USA, 21157 _nSAN 201-3975
040			_aDLC _beng _erda _cDLC _dOCLCO _dSSH _dOCLCF _dJSE _dFEM _dQQ3 _dJTH _dYDX _dCZA _dOCLCO _dJQM
042			_apcc
043			_an-us---
050	0	0	_aHD9995.H423 _bU627 2018
082	0	0	_a338.7/681761 _223
084			_aBUS025000 _aBUS027000 _aTEC059000 _2bisacsh
100	1		_aCarreyrou, John, _eauthor. _9128457
245	1	0	_aBad blood : _bsecrets and lies in a Silicon Valley startup /
250			_aFirst edition.
264		1	_aNew York : _bAlfred A. Knopf, _c2018.
264		4	_c�2018
300			_ax, 339 pages ; _c25 cm
504			_aIncludes bibliographical references and index.
505	0		_aA purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\day -- Going live -- Unicorn -- The grandson -- Fame -- The hippocratic oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
520			_a"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
610	2	0	_aTheranos (Firm) _xHistory. _9128458
650		0	_aHematologic equipment industry _zUnited States. _9128459
650		0	_aFraud _zUnited States. _9128460
655		7	_aHistory. _2fast _9128461
942			_2ddc _cNF
999			_c63235 _d63235